CL:0000723

Name:	somatic stem cell
Namespace:	cell
Definition:	"A stem cell that can give rise to cell types of the body other than those of the germ-line." [GO:0048103]
Xrefs:	Expandlinks: FMA:63368

Ontology association <br>Each term has an is_a parent in the Cell ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to Cell ontologies.<br><br>link to ontology dataset<br>data

---

Parents

is_a:	CL:0000034(stem cell),CL:0002371(somatic cell)

Children

is a:	CL:0000035 (single fate stem cell),CL:0000048 (multi fate stem cell),CL:0002248 (pluripotent stem cell),CL:1000428 (stem cell of epidermis)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples<br>It includes FANTOM5 samples that overlay the Cell ontology.

---

Human (Homo sapiens)

• 10447-106F6
• 10568-108B1 (mesenchymal stem cell line:Hu5/E18)
• 10813-111B3 (normal embryonic palatal mesenchymal cell line:HEPM)
• 11214-116A8 (Mesenchymal stem cells - umbilical, donor0)
• 11217-116B2 (Mesenchymal stem cells - adipose, donor0)
• 11218-116B3 (Mesenchymal stem cells - hepatic, donor0)
• 11219-116B4 (Mesenchymal Stem Cells - Vertebral, donor1)
• 11229-116C5 (CD14+ monocyte derived endothelial progenitor cells, donor1)
• 11240-116D7 (Skeletal Muscle Satellite Cells, donor1)
• 11271-116H2 (Hair Follicle Dermal Papilla Cells, donor1)

... further results Mouse (Mus musculus)

• 10447-106F6
• 10568-108B1 (mesenchymal stem cell line:Hu5/E18)
• 10813-111B3 (normal embryonic palatal mesenchymal cell line:HEPM)
• 11214-116A8 (Mesenchymal stem cells - umbilical, donor0)
• 11217-116B2 (Mesenchymal stem cells - adipose, donor0)
• 11218-116B3 (Mesenchymal stem cells - hepatic, donor0)
• 11219-116B4 (Mesenchymal Stem Cells - Vertebral, donor1)
• 11229-116C5 (CD14+ monocyte derived endothelial progenitor cells, donor1)
• 11240-116D7 (Skeletal Muscle Satellite Cells, donor1)
• 11271-116H2 (Hair Follicle Dermal Papilla Cells, donor1)

... further results

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with CL:0000723 (somatic stem cell), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

---

Copy Excel CSV PDF

Search:

P-value	FFCP	Short description

P-value	FFCP	Short description
2.78e-51	FFCP PHASE1:Hg19::chr19:48828606..48828637,+	p2@EMP3
2.78e-51	FFCP PHASE2:Hg19::chr19:48828606..48828637,+	p2@EMP3
9.5e-49	FFCP PHASE1:Hg19::chr2:182322231..182322262,+	p2@ITGA4
9.5e-49	FFCP PHASE2:Hg19::chr2:182322231..182322262,+	p2@ITGA4
1.49e-48	FFCP PHASE2:Hg19::chr1:145096480..145096513,+	p2@SEC22B
1.49e-48	FFCP PHASE1:Hg19::chr1:145096480..145096513,+	p2@SEC22B
1.29e-46	FFCP PHASE2:Hg19::chr2:74781828..74781898,+	p1@DOK1
1.29e-46	FFCP PHASE1:Hg19::chr2:74781828..74781898,+	p1@DOK1
1.42e-44	FFCP PHASE2:Mm9::chr1:146456236..146456244,-	p1@ENSMUST00000157471
1.42e-44	FFCP PHASE1:Mm9::chr1:146456236..146456244,-	p1@ENSMUST00000157471
1.2e-43	FFCP PHASE2:Mm9::chr3:32910877..32910881,+	p1@ENSMUST00000122716
1.2e-43	FFCP PHASE1:Mm9::chr3:32910877..32910881,+	p1@ENSMUST00000122716
5.0e-43	FFCP PHASE1:Hg19::chr2:114647617..114647739,+	p1@ACTR3
5.0e-43	FFCP PHASE2:Hg19::chr2:114647617..114647739,+	p1@ACTR3
2.32e-42	FFCP PHASE2:Mm9::chr19:18807230..18807233,+	p1@ENSMUST00000083007
2.32e-42	FFCP PHASE1:Mm9::chr19:18807230..18807233,+	p1@ENSMUST00000083007
4.79e-42	FFCP PHASE1:Hg19::chr5:78281092..78281154,-	p1@ARSB
4.79e-42	FFCP PHASE2:Hg19::chr5:78281092..78281154,-	p1@ARSB
7.27e-42	FFCP PHASE2:Hg19::chr19:48828647..48828658,+	p3@EMP3
7.27e-42	FFCP PHASE1:Hg19::chr19:48828647..48828658,+	p3@EMP3
1.17e-41	FFCP PHASE2:Hg19::chr6:31704075..31704106,-	p2@CLIC1
1.17e-41	FFCP PHASE1:Hg19::chr6:31704075..31704106,-	p2@CLIC1
2.16e-41	FFCP PHASE1:Hg19::chr11:504446..504486,-	p4@RNH1
2.16e-41	FFCP PHASE2:Hg19::chr11:504446..504486,-	p4@RNH1
5.63e-40	FFCP PHASE1:Mm9::chr4:32085713..32085717,-	p1@ENSMUST00000122491
5.63e-40	FFCP PHASE2:Mm9::chr4:32085713..32085717,-	p1@ENSMUST00000122491
9.7e-40	FFCP PHASE1:Hg19::chr16:50300440..50300485,+	p1@ADCY7
9.7e-40	FFCP PHASE2:Hg19::chr16:50300440..50300485,+	p1@ADCY7
1.07e-39	FFCP PHASE1:Hg19::chr1:183604794..183604908,-	p1@ARPC5
1.07e-39	FFCP PHASE2:Hg19::chr1:183604794..183604908,-	p1@ARPC5
3.99e-39	FFCP PHASE2:Mm9::chr3:19460250..19460260,+	p1@ENSMUST00000083241
3.99e-39	FFCP PHASE1:Mm9::chr3:19460250..19460260,+	p1@ENSMUST00000083241
5.79e-39	FFCP PHASE1:Mm9::chr11:48596086..48596090,+	p@chr11:48596086..48596090, +
5.79e-39	FFCP PHASE2:Mm9::chr11:48596086..48596090,+	p@chr11:48596086..48596090, +
2.16e-38	FFCP PHASE1:Mm9::chr16:72264646..72264650,-	p@chr16:72264646..72264650, -
2.16e-38	FFCP PHASE2:Mm9::chr16:72264646..72264650,-	p@chr16:72264646..72264650, -
4.54e-38	FFCP PHASE1:Mm9::chr4:131826124..131826129,-	p1@ENSMUST00000104135
4.54e-38	FFCP PHASE2:Mm9::chr4:131826124..131826129,-	p1@ENSMUST00000104135
5.72e-38	FFCP PHASE2:Mm9::chr19:26334980..26334985,-	p1@ENSMUST00000122640
5.72e-38	FFCP PHASE1:Mm9::chr19:26334980..26334985,-	p1@ENSMUST00000122640
5.74e-38	FFCP PHASE2:Hg19::chr15:90358115..90358195,-	p3@ANPEP
5.74e-38	FFCP PHASE1:Hg19::chr15:90358115..90358195,-	p3@ANPEP
6.45e-38	FFCP PHASE2:Hg19::chr12:75874580..75874611,+	p2@GLIPR1
6.45e-38	FFCP PHASE1:Hg19::chr12:75874580..75874611,+	p2@GLIPR1
1.1e-37	FFCP PHASE1:Hg19::chr2:182322070..182322155,+	p1@ITGA4
1.1e-37	FFCP PHASE2:Hg19::chr2:182322070..182322155,+	p1@ITGA4
4.91e-37	FFCP PHASE1:Hg19::chr11:504867..504925,-	p3@RNH1
4.91e-37	FFCP PHASE2:Hg19::chr11:504867..504925,-	p3@RNH1
9.41e-37	FFCP PHASE2:Hg19::chr15:73076030..73076121,-	p1@ADPGK
9.41e-37	FFCP PHASE1:Hg19::chr15:73076030..73076121,-	p1@ADPGK
1.33e-36	FFCP PHASE2:Mm9::chr3:72925786..72925790,+	p@chr3:72925786..72925790, +
1.33e-36	FFCP PHASE1:Mm9::chr3:72925786..72925790,+	p@chr3:72925786..72925790, +
1.48e-36	FFCP PHASE2:Hg19::chr12:110888103..110888172,-	p1@ARPC3
1.48e-36	FFCP PHASE1:Hg19::chr12:110888103..110888172,-	p1@ARPC3
4.77e-36	FFCP PHASE2:Mm9::chr14:106660467..106660471,-	p1@ENSMUST00000083259
4.77e-36	FFCP PHASE1:Mm9::chr14:106660467..106660471,-	p1@ENSMUST00000083259
5.63e-36	FFCP PHASE1:Hg19::chr18:18691563..18691610,-	p4@ROCK1
5.63e-36	FFCP PHASE2:Hg19::chr18:18691563..18691610,-	p4@ROCK1
6.93e-36	FFCP PHASE2:Hg19::chr1:46016703..46016755,+	p2@AKR1A1
6.93e-36	FFCP PHASE1:Hg19::chr1:46016703..46016755,+	p2@AKR1A1
7.68e-36	FFCP PHASE1:Hg19::chr15:90358048..90358103,-	p1@ANPEP
7.68e-36	FFCP PHASE2:Hg19::chr15:90358048..90358103,-	p1@ANPEP
8.08e-36	FFCP PHASE1:Hg19::chr1:20987936..20987969,-	p2@DDOST
8.08e-36	FFCP PHASE2:Hg19::chr1:20987936..20987969,-	p2@DDOST
1.33e-35	FFCP PHASE1:Mm9::chr10:104477319..104477348,+	p1@ENSMUST00000082498
1.33e-35	FFCP PHASE2:Mm9::chr10:104477319..104477348,+	p1@ENSMUST00000082498
3.68e-35	FFCP PHASE1:Hg19::chr2:102091566..102091581,-	p1@RFX8
3.68e-35	FFCP PHASE2:Hg19::chr2:102091566..102091581,-	p1@RFX8
4.08e-35	FFCP PHASE1:Hg19::chr11:504942..504959,-	p5@RNH1
4.08e-35	FFCP PHASE2:Hg19::chr11:504942..504959,-	p5@RNH1
4.14e-35	FFCP PHASE2:Hg19::chr9:35112376..35112395,-	p@chr9:35112376..35112395, -
4.14e-35	FFCP PHASE1:Hg19::chr9:35112376..35112395,-	p@chr9:35112376..35112395, -
4.18e-35	FFCP PHASE1:Mm9::chr5:115939562..115939592,-	p@chr5:115939562..115939592, -
4.18e-35	FFCP PHASE2:Mm9::chr5:115939562..115939592,-	p@chr5:115939562..115939592, -
4.79e-35	FFCP PHASE2:Mm9::chr5:115939465..115939467,+	p1@ENSMUST00000102044
4.79e-35	FFCP PHASE1:Mm9::chr5:115939465..115939467,+	p1@ENSMUST00000102044
5.54e-35	FFCP PHASE2:Hg19::chr10:17271909..17272033,-	p1@uc001iot.1
5.54e-35	FFCP PHASE1:Hg19::chr10:17271909..17272033,-	p1@uc001iot.1
9.86e-35	FFCP PHASE1:Hg19::chrX:48432892..48432916,+	p1@RBM3
9.86e-35	FFCP PHASE2:Hg19::chrX:48432892..48432916,+	p1@RBM3
1.27e-34	FFCP PHASE1:Hg19::chr20:61584026..61584096,+	p1@SLC17A9
1.27e-34	FFCP PHASE2:Hg19::chr20:61584026..61584096,+	p1@SLC17A9
1.48e-34	FFCP PHASE2:Mm9::chr11:68834407..68834410,+	p@chr11:68834407..68834410, +
1.48e-34	FFCP PHASE1:Mm9::chr11:68834407..68834410,+	p@chr11:68834407..68834410, +
3.9e-34	FFCP PHASE2:Mm9::chr15:80870069..80870076,+	p1@ENSMUST00000082653
3.9e-34	FFCP PHASE1:Mm9::chr15:80870069..80870076,+	p1@ENSMUST00000082653
4.09e-34	FFCP PHASE1:Hg19::chr12:75874561..75874574,+	p3@GLIPR1
4.09e-34	FFCP PHASE2:Hg19::chr12:75874561..75874574,+	p3@GLIPR1
5.21e-34	FFCP PHASE2:Hg19::chr2:192542577..192542595,-	p@chr2:192542577..192542595, -
5.21e-34	FFCP PHASE1:Hg19::chr2:192542577..192542595,-	p@chr2:192542577..192542595, -
7.39e-34	FFCP PHASE2:Hg19::chr12:75874525..75874549,+	p1@GLIPR1
7.39e-34	FFCP PHASE1:Hg19::chr12:75874525..75874549,+	p1@GLIPR1
7.52e-34	FFCP PHASE1:Mm9::chr2:3208787..3208789,-	p1@ENSMUST00000082795
7.52e-34	FFCP PHASE2:Mm9::chr2:3208787..3208789,-	p1@ENSMUST00000082795
8.98e-34	FFCP PHASE2:Hg19::chr3:50378235..50378286,-	p2@RASSF1
8.98e-34	FFCP PHASE1:Hg19::chr3:50378235..50378286,-	p2@RASSF1
1.02e-33	FFCP PHASE1:Hg19::chr14:73930324..73930350,-	p2@NUMB
1.02e-33	FFCP PHASE2:Hg19::chr14:73930324..73930350,-	p2@NUMB
1.08e-33	FFCP PHASE1:Hg19::chr21:26934434..26934452,+	p1@MIR155HG
1.08e-33	FFCP PHASE2:Hg19::chr21:26934434..26934452,+	p1@MIR155HG

Showing 1 to 100 of 100 entries